New bypass device could spare rectal cancer patients from stoma surgery
Disease control
Recruiting now
This trial tests a temporary bypass device called CG-100 in 250 rectal cancer patients undergoing surgery. The device is placed inside the bowel to protect the surgical connection, potentially reducing the need for a temporary stoma. Researchers will compare stoma rates and compl…
Phase: NA • Sponsor: Colospan Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC